Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Scherer

Showing results (141-150 of 188) with videos related to

Pageof 19
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|August 24, 1999
Cutting edge: activation of NK T cells by CD1d and alpha-galactosylceramide directs conventional T cells to the acquisition of a Th2 phenotypeN Singh, S Hong, D C Scherer, et al.
Clinical Neuropathology|August 26, 1998
Gerstmann-Sträussler-Scheinker disease with A117V mutation in a second French-Alsatian familyN Heldt, J W Boellaard, P Brown, et al.
Immunity|December 1, 1996
Corepression of RelA and c-rel inhibits immunoglobulin kappa gene transcription and rearrangement in precursor B lymphocytesD C Scherer, J A Brockman, H H Bendall, et al.
The Lancet. Neurology|December 16, 2014
Site of effect of LY2951742 for migraine prophylaxis--authors' replyDavid W Dodick, Peter J Goadsby, Egilius L H Spierings, et al.
The Lancet. Neurology|August 16, 2014
Safety and efficacy of LY2951742, a monoclonal antibody to calcitonin gene-related peptide, for the prevention of migraine: a phase 2, randomised, double-blind, placebo-controlled studyDavid W Dodick, Peter J Goadsby, Egilius L H Spierings, et al.
Revue Neurologique|November 9, 2010
[Hereditary optic atrophies]C Scherer, V Procaccio, M Ferre, et al.
Molecular and Cellular Biology|May 1, 1996
Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1: a potential mechanism for constitutive induction of NF-kappaBT A McKinsey, J A Brockman, D C Scherer, et al.
BMC Infectious Diseases|January 2, 2010
Cost-effectiveness analysis of PCR for the rapid diagnosis of pulmonary tuberculosisLuciene C Scherer, Rosa D Sperhacke, Antonio Ruffino-Netto, et al.
Clinical Endocrinology|April 1, 1996
Risk factors for secondary hyperparathyroidism in a nursing home populationM S Stein, S C Scherer, S L Walton, et al.
European Journal of Neurology|October 19, 2007
Cognitive changes in asymptomatic carriers of the Huntington disease mutation geneC Verny, P Allain, A Prudean, et al.
Pageof 19

Showing results (141-150 of 188) with videos related to

Sort By:
Pageof 19
Journal of Immunology (Baltimore, Md. : 1950)|August 24, 1999
Cutting edge: activation of NK T cells by CD1d and alpha-galactosylceramide directs conventional T cells to the acquisition of a Th2 phenotypeN Singh, S Hong, D C Scherer, et al.
Clinical Neuropathology|August 26, 1998
Gerstmann-Sträussler-Scheinker disease with A117V mutation in a second French-Alsatian familyN Heldt, J W Boellaard, P Brown, et al.
Immunity|December 1, 1996
Corepression of RelA and c-rel inhibits immunoglobulin kappa gene transcription and rearrangement in precursor B lymphocytesD C Scherer, J A Brockman, H H Bendall, et al.
The Lancet. Neurology|December 16, 2014
Site of effect of LY2951742 for migraine prophylaxis--authors' replyDavid W Dodick, Peter J Goadsby, Egilius L H Spierings, et al.
The Lancet. Neurology|August 16, 2014
Safety and efficacy of LY2951742, a monoclonal antibody to calcitonin gene-related peptide, for the prevention of migraine: a phase 2, randomised, double-blind, placebo-controlled studyDavid W Dodick, Peter J Goadsby, Egilius L H Spierings, et al.
Revue Neurologique|November 9, 2010
[Hereditary optic atrophies]C Scherer, V Procaccio, M Ferre, et al.
Molecular and Cellular Biology|May 1, 1996
Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1: a potential mechanism for constitutive induction of NF-kappaBT A McKinsey, J A Brockman, D C Scherer, et al.
BMC Infectious Diseases|January 2, 2010
Cost-effectiveness analysis of PCR for the rapid diagnosis of pulmonary tuberculosisLuciene C Scherer, Rosa D Sperhacke, Antonio Ruffino-Netto, et al.
Clinical Endocrinology|April 1, 1996
Risk factors for secondary hyperparathyroidism in a nursing home populationM S Stein, S C Scherer, S L Walton, et al.
European Journal of Neurology|October 19, 2007
Cognitive changes in asymptomatic carriers of the Huntington disease mutation geneC Verny, P Allain, A Prudean, et al.
Pageof 19